Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
The Lancet. Rheumatology|November 1, 2024
Identification of red flags for IgG4-related disease: an international European Reference Network for Rare Connective Tissue Diseases frameworkEmanuel Della-Torre, Rosaria Talarico, Jose Ballarin, et al.
Rheumatology (Oxford, England)|January 25, 2021
Childhood-onset of primary Sjögren's syndrome: phenotypic characterization at diagnosis of 158 childrenManuel Ramos-Casals, Nihan Acar-Denizli, Arjan Vissink, et al.
Autoimmunity Reviews|November 9, 2018
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysisRoberto Giacomelli, Antonella Afeltra, Alessia Alunno, et al.
Clinical and Experimental Rheumatology|August 30, 2019
Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patientsSoledad Retamozo, Nihan Acar-Denizli, Astrid Rasmussen, et al.
Autoimmunity Reviews|December 16, 2020
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' ConsensusRoberto Giacomelli, Antonella Afeltra, Elena Bartoloni, et al.
Clinical and Experimental Rheumatology|November 29, 2023
Influence of exposure to climate-related hazards in the phenotypic expression of primary Sjögren's syndromeAlejandra Flores-Chávez, Pilar Brito-Zerón, Wan-Fai Ng, et al.
Frontiers in Pharmacology|June 30, 2017
Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational StudySerena Colafrancesco, Roberta Priori, Guido Valesini, et al.
Frontiers in Pharmacology|April 20, 2019
Long-Term Retention Rate of Anakinra in Adult Onset Still's Disease and Predictive Factors for Treatment ResponseAntonio Vitale, Giulio Cavalli, Serena Colafrancesco, et al.
Frontiers in Pharmacology|November 9, 2016
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational StudyAntonio Vitale, Antonella Insalaco, Paolo Sfriso, et al.
Clinical and Experimental Rheumatology|November 29, 2023
Exposure to air pollution as an environmental determinant of how Sjögren's disease is expressed at diagnosisPilar Brito-Zerón, Alejandra Flores-Chávez, Wan-Fai Ng, et al.
Pageof 13